VGG312491084
© BusinessWire
12.01.2026
ESTA
LISTED
NASDAQ
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited financial results for the three months and fiscal year ended December 31, 2025.
Establishment Labs’ preliminary unaudit...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 44th Annual J.P Morgan Healthcare Con...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
ESTA
LISTED
NASDAQ
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted Motiva® implants for approval in primary and revision breast reconstruction to the U.S. Food and Drug Administration (FDA...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
07.11.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at Jefferies London Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference.
Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
05.11.2025
ESTA
LISTED
NASDAQ
Establishment Labs Reports Third Quarter 2025 Financial Results
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter Highlights and Outlook (Unaudited)
Third quarter worldwide r...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025, and will host a confe...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ESTA
LISTED
NASDAQ
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the publication of “The 3-Year Results of a 100-Patient Prospective Study of Safety and Effectiveness of Mia Femtech” in the Aesthetic Surgery Journal....
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ESTA
LISTED
NASDAQ
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced publication of its 2025 Post-Market Surveillance (PMS) Report. The report is being released ahead of the annual meeting of the American Society of Pl...
Themefolio
Profiler
Peergroup
© BusinessWire
25.07.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025, and will host a conference ca...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
ESTA
LISTED
NASDAQ
Establishment Labs Hosting Investor Day on June 12
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET.
A live and archived webcast of presentat...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at Jefferies Global Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies Global Healthcare Conference.
Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Offi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
ESTA
LISTED
NASDAQ
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Peter Caldini as Chief Executive Officer effective May 7, 2025. Mr. Caldini has served as Interim CEO since March 1, 2025, w...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
07.05.2025
ESTA
LISTED
NASDAQ
Establishment Labs Reports First Quarter 2025 Financial Results
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2025.
First Quarter Highlights and Outlook
First quarter worldwide revenue of $41.4...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2025, after the market closes on Wednesday, May 7, 2025, and will host a conference cal...
Themefolio
Profiler
Peergroup
© BusinessWire
10.04.2025
ESTA
LISTED
NASDAQ
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, provided preliminary first quarter 2025 sales results and announced that it will host an analyst and investor event in New York City on June 12, 2025.
Establi...
Themefolio
Profiler
Peergroup
© BusinessWire
20.03.2025
ESTA
LISTED
NASDAQ
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today of an update on the Motiva US IDE Study. The update will include five-year patient follow-up data for primary augmentation subject...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
ESTA
LISTED
NASDAQ
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
News Preview
The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants®
NEW YORK, March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announce...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
ESTA
LISTED
NASDAQ
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the fourth quarter and full year ended December 31, 2024 and reaffirmed 2025 guidance.
Fourth Quarter Highlights and Ou...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in TD Cowen's 45th Annual Health Care Conference.
Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Den...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in a fireside chat at Citi's 2025 Unplugged Medtech and Life Sciences Access Day.
Juan José Chacón-Quirós, Chief Executive O...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
ESTA
LISTED
NASDAQ
Establishment Labs Launches Preservé™
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness in breast aesthetics and reconstruction, announced it has launched Preservé™ in Brazil, the first country in its global rollout. Preservé is the second product in the Company’s minimally invasive platform, buildin...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2024, after the market closes on Wednesday, February 26, 2025, and will host a confe...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
ESTA
LISTED
NASDAQ
Establishment Labs Announces CEO Transition
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness in breast aesthetics and reconstruction, announced today that after twenty years as Chief Executive Officer (CEO), Juan José Chacón-Quirós has decided to retire as CEO, effective March 1, 2025. Peter Caldini, curr...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 43rd Annual J.P...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2024
ESTA
LISTED
NASDAQ
Establishment Labs Announces Participation in Upcoming Investment Conferences
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences.
Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
ESTA
LISTED
NASDAQ
Establishment Labs Announces $50 Million Registered Direct Offering
News Preview
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
ESTA
LISTED
NASDAQ
Establishment Labs Reports Third Quarter 2024 Financial Results
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024.
Third Quarter Highlights and Outlook
Third quarter worldwide revenue of $4...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
ESTA
LISTED
NASDAQ
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of three-year clinical results with Mia Femtech™ at the 9th Annual World Symposium on Ergonomic Implants (WSEI) being held this week...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024, and will host a confer...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2024
ESTA
LISTED
NASDAQ
Establishment Labs Publishes 2024 Post Market Surveillance Report
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has published its 2024 Post Market Surveillance (PMS) Report.
“It is fitting that as we publish our 2024 PMS report, we begin broadly shippi...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2024
ESTA
LISTED
NASDAQ
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that the first patients in the United States have successfully undergone breast augmentation with Motiva® Implants.
“With the FDA approval las...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2024
ESTA
LISTED
NASDAQ
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
